NVCT

Conviction 85HealthcareScan · Mon, Aug 10, 2026

NVCT$18.91-0.21%

ResistanceSupportVol 14

Vol MA14 256.01K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Nuvectis Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.nuvectis.com ↗

Price18.91

Change-0.21%

Gap-0.21%

Rel volume1.48×

Avg volume255.41K

Avg $ vol5.03M

SMA 2019.67

SMA 5017.28

SMA 20010.44

Price vs 50+9.40%

Price vs 200+81.09%

MA stackbullish

50/200 cross—

Supertrenddown · 23.47

RSI (14)49

MACD hist-0.36

MACD crossbear · 4d

Stoch %K / %D20 / 19

ADX (14)25

+DI / −DI20 / 21

RSI divergence—

MACD divergence—

ATR %+8.70%

ADR %7.38%

52w high28.53

52w low5.65

From 52w high-33.72%

Above 52w low+234.69%

New 52w highNo

SqueezeOn · 4d

Bollinger width23.54%

%B0.34

Donchian pos19.50%

Donchian high23.12

Donchian low17.89

AVWAP (52w high)19.78

vs AVWAP high-4.38%

AVWAP (52w low)15.59

vs AVWAP low+21.26%

OBV trendFlat

Chaikin MF (20)0.09

Today vs 20d1.48×

Avg vol (14d)256K

Avg vol (20d)255.41K

Avg $ vol (20d)5.03M

Market cap616.12M

RS 3m (vs SPY)+77.93%

RS 6m (vs SPY)+111.21%

RS line new highNo

Trend template7/8

Technical rank82.3

1 week-12.45%

1 month+3.05%

3 months+62.32%

6 months+112.71%

1 year+206.48%

YTD+122.21%

P/E-23.30

P/B67.84

P/S—

P/FCF—

EPS-1.32

Div yield—

ROE-291.15%

ROA-118.17%

Debt/Eq—

Current1.68

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-39.17%

Price target34.00

Target upside79.80%

Analyst ratingBuy

Institutional17.89%

Ent. value593.96M

Revenue—

Net income-7.02M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out26.53M

Employees13

ListedFri, Feb 4, 2022

Free float15.47M

Float %58.4%

Short interest1.51M

Days to cover4.0d

Short volume64.8%

Squeeze score63 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.30 vs −$0.25

Last surprise-20.0% miss

Setup gradeA+

Conviction85 / 100

Pattern quality—

Tech rank82.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance26.20

Support17.83

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jun 1
1 scan
→
Setting up
Jul 28
1 scan

Congress activity

Disclosed STOCK Act trades in NVCT

All disclosures →

No recent disclosed trades by Congress in NVCT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NVCT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Carson Michael J. Vice President, Finance · Common Stock · 2026-08-03	Grant	30K	—	2026-08-03	2026-08-05

SEC filings

EDGAR filings in NVCT · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.